Showing results out of
EMBL Hamburg is located at the PETRA III synchrotron, which in the future, will be upgraded to PETRA IV. Selina Storm is theEMBL@PETRA IV Programme Manager. Here, she speaks about her role and the benefits of PETRA IV for EMBL.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
Kirill Kovalev, an EMBL Hamburg researcher, is studying the structure of an ancient bacterial molecule to help scientists control brain cell activity
EMBLetc2022
Ken Holmes, outstanding pioneer of structural biology and founder of EMBL´s Hamburg site, died on 2 November 2021 at the age of 87.
PEOPLE & PERSPECTIVES2021
alumnipeople-perspectives
EMBL alumni Ilaria Piazza and Ken Holmes have been recognised for their outstanding contributions, and will receive their awards as part of the celebrations for EMBL World Alumni Day.
PEOPLE & PERSPECTIVES2021
alumnipeople-perspectives
EMBL’s Melissa Graewert and colleagues are taking a structural biologist’s approach to better understanding nanoplastic particles.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
EMBL’s EU Green Week event showcased various ways molecular biology research can help solve environmental challenges.
LAB MATTERS2021
lab-matters
A workshop run by EMBL Hamburg explored opportunities for structural biology at the future, upgraded PETRA IV synchrotron.
SCIENCE & TECHNOLOGY2021
eventsscience-technology
Zehra Sayers explains what makes the SESAME synchrotron special, why we should not fear failure, and why curiosity is her biggest driver.
PEOPLE & PERSPECTIVES2021
alumnipeople-perspectives
Using EMBL Hamburg’s world-class structural biology infrastructure, researchers advance the folding of protein ‘origami’ designed in the lab.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
EMBL researchers are studying COVID-19-related molecules by exposing them to high-brilliance X-ray beams. The Svergun group at EMBL Hamburg is using biological small-angle X-ray scattering (SAXS) as part of a global effort by scientists to elucidate the structural organisation of SARS-CoV-2…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Scientists at EMBL Hamburg and Karolinska Institutet Stockholm aim to find synthetic antibodies – known as nanobodies – that bind a surface protein of the novel SARS-CoV-2 coronavirus. Nanobodies could prevent the virus from entering human cells and causing COVID-19.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL instrumentation teams adapting tech to run biological experiments on the synchrotron after its upgrade
LAB MATTERSSCIENCE & TECHNOLOGY2018
lab-mattersscience-technology
EMBL and the European synchrotron ESRF extend their Joint Structural Biology Group
CONNECTIONSLAB MATTERS2017
connectionslab-matters
EMBL alumna Zehra Sayers key driver of the Middle East’s first synchrotron project
PEOPLE & PERSPECTIVES2017
alumnipeople-perspectives
The German Federal Ministry for Education and Research (BMBF) has awarded 8.8 Million Euro to the Hamburg Outstation of the European Molecular Biology Laboratory (EMBL) for the construction of an Integrated Research Facility for Structural Biology at the new PETRA-III storage ring of the German…
LAB MATTERS2007
lab-matters
No results found